Alpa Labs - Alpa Laboratories Share Price

95.220.16 (0.16%)
Volume: 11,633

Closed
Last Updated On: 08 Sep, 2025, 03:44 PM IST

STOCK SCORE

ETPrime Only

95.220.16 (0.16%)
Volume: 11,633

Alpa Labs share price insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 26.75%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.79% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Alpa Labs Share Price Update
Alpa Laboratories Ltd. share price moved up by 0.16% from its previous close of Rs 95.07. Alpa Laboratories Ltd. stock last traded price is 95.22
Share Price Value
Today/Current/Last 95.2295.00
Previous Day 95.0795.14

Share Price	Value
Today/Current/Last	95.2295.00
Previous Day	95.0795.14

InsightsAlpa Labs

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

7.64

EPS - TTM

(₹)

12.47

MCap

(₹ Cr.)

200.35

Sectoral MCap Rank

PB Ratio

(x)

1.17

Div Yield

(%)

0.00

Face Value

(₹)

10.00

Beta

-0.23

VWAP

(₹)

95.25

52W H/L

(₹)

144.50 / 90.36

Alpa Labs Share Price Returns

1 Day	0.16%
1 Week	-1.18%
1 Month	-1.07%
3 Months	-3.86%
1 Year	-18.01%
3 Years	50.78%
5 Years	242.52%

ET Stock ScreenersTop Score Companies

Check whether Alpa Labs belongs to analysts' top-rated companies list?

View Stock Screeners

Alpa Labs News & Analysis

View all Alpa Labs Share News & Announcements

Alpa Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Alpa Labs Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Alpa Labs Financials

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 26.75%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.79% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	31.06	42.40	34.95	31.85	26.60
Total Income Growth (%)	-26.75	21.30	9.74	19.71	-3.51
Total Expenses	19.24	40.30	25.96	22.15	21.46
Total Expenses Growth (%)	-52.26	55.27	17.21	3.22	4.12
EBIT	11.82	2.09	8.99	9.70	5.15
EBIT Growth (%)	465.11	-76.75	-7.29	88.46	-26.10
Profit after Tax (PAT)	11.77	-2.12	8.90	7.69	5.10
PAT Growth (%)	-	-123.86	15.81	50.83	43.43
EBIT Margin (%)	38.05	4.93	25.73	30.46	19.35
Net Profit Margin (%)	37.89	-5.01	25.47	24.13	19.16
Basic EPS (₹)	5.59	-0.95	4.23	3.66	2.42

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	31.07	42.35	34.95	31.85	26.60
Total Income Growth (%)	-26.64	21.18	9.74	19.71	-3.46
Total Expenses	19.24	40.05	25.96	22.19	21.43
Total Expenses Growth (%)	-51.96	54.30	16.96	3.59	4.03
EBIT	11.83	2.30	8.99	9.65	5.18
EBIT Growth (%)	414.35	-74.43	-6.84	86.45	-25.60
Profit after Tax (PAT)	11.78	-1.95	8.89	7.63	5.12
PAT Growth (%)	-	-121.90	16.58	48.86	44.50
EBIT Margin (%)	38.07	5.43	25.73	30.31	19.46
Net Profit Margin (%)	37.90	-4.60	25.44	23.95	19.26
Basic EPS (₹)	5.60	-0.86	4.24	3.63	2.44

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	135.80	123.63	102.32	123.04	101.95
Total Revenue Growth (%)	9.84	20.82	-16.84	20.69	14.70
Total Expenses	110.13	102.95	86.43	103.48	91.16
Total Expenses Growth (%)	6.98	19.11	-16.47	13.51	6.04
Profit after Tax (PAT)	19.50	16.78	12.58	14.09	7.25
PAT Growth (%)	16.25	33.33	-10.71	94.45	291.01
Operating Profit Margin (%)	23.03	19.35	17.33	17.61	11.13
Net Profit Margin (%)	17.34	15.42	13.53	12.55	7.42
Basic EPS (₹)	9.34	8.01	5.88	6.70	3.44

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	135.76	123.61	102.36	123.06	101.96
Total Revenue Growth (%)	9.82	20.76	-16.82	20.69	14.65
Total Expenses	109.92	102.94	86.43	103.48	91.17
Total Expenses Growth (%)	6.78	19.10	-16.47	13.50	8.72
Profit after Tax (PAT)	19.68	16.78	12.62	14.13	7.26
PAT Growth (%)	17.30	32.90	-10.63	94.45	78.13
Operating Profit Margin (%)	23.38	19.37	17.37	17.65	11.16
Net Profit Margin (%)	17.62	15.42	13.58	12.58	7.44
Basic EPS (₹)	9.42	8.01	5.90	6.71	3.46

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	222.59	182.37	167.27	155.24	140.37
Total Assets Growth (%)	22.05	9.03	7.75	10.59	15.67
Total Liabilities	51.16	30.46	32.69	33.51	32.73
Total Liabilities Growth (%)	67.94	-6.82	-2.43	2.39	56.00
Total Equity	171.43	151.91	134.58	121.73	107.64
Total Equity Growth (%)	12.85	12.88	10.55	13.09	7.24
Current Ratio (x)	4.10	5.74	4.67	4.43	3.73
Total Debt to Equity (x)	0.00	0.03	0.02	0.05	0.00
Contingent Liabilities	0.00	3.68	3.25	5.28	5.28

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	232.95	192.42	177.50	165.14	150.23
Total Assets Growth (%)	21.06	8.41	7.48	9.92	14.50
Total Liabilities	51.15	30.45	32.98	33.50	32.71
Total Liabilities Growth (%)	67.98	-7.67	-1.55	2.42	55.98
Total Equity	181.80	161.97	144.53	131.64	117.52
Total Equity Growth (%)	12.24	12.07	9.79	12.01	6.61
Current Ratio (x)	4.08	5.70	4.95	4.78	3.69
Total Debt to Equity (x)	0.00	0.03	0.02	0.04	0.00
Contingent Liabilities	0.00	3.68	3.25	5.28	5.28

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 7.06 cr is 0.36 times compared to the reported net profit of Rs 19.5 cr. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 1.1 cr for investing activities which is an YoY decrease of 91.74%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	7.06	3.65	8.90	2.17	-1.69
Net Cash used in Investing Activities	-1.10	-13.34	2.13	-15.61	5.86
Net Cash flow from Financing Activities	-5.48	2.58	-3.79	5.43	0.19
Net Cash Flow	0.48	-7.10	7.24	-8.01	4.35
Closing Cash & Cash Equivalent	3.59	3.11	8.81	2.50	10.52
Closing Cash & Cash Equivalent Growth (%)	15.36	-64.71	252.56	-76.24	70.65
Total Debt/ CFO (x)	0.00	1.44	0.26	2.69	-0.01

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	18.39	3.70	8.82	2.20	-1.45
Net Cash used in Investing Activities	-5.51	-12.45	2.14	-17.18	5.82
Net Cash flow from Financing Activities	-12.49	2.26	-3.48	5.41	-0.03
Net Cash Flow	0.39	-6.49	7.48	-9.57	4.34
Closing Cash & Cash Equivalent	3.05	3.66	10.13	0.67	10.26
Closing Cash & Cash Equivalent Growth (%)	-16.64	-63.90	1,416.95	-93.49	73.37
Total Debt/ CFO (x)	0.00	1.42	0.29	2.65	-0.01

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	11.37	11.04	9.34	11.57	6.73
Return on Capital Employed (%)	14.72	13.63	11.90	15.97	10.07
Return on Assets (%)	8.76	9.19	7.52	9.07	5.16
Interest Coverage Ratio (x)	121.23	64.02	78.01	97.84	139.46
Asset Turnover Ratio (x)	0.56	0.62	0.58	0.73	69.49
Price to Earnings (x)	11.24	10.47	9.00	10.38	10.50
Price to Book (x)	1.28	1.16	0.84	1.20	0.71
EV/EBITDA (x)	7.72	7.79	6.11	6.98	5.42
EBITDA Margin (%)	24.98	21.14	18.76	19.09	12.39

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	10.82	10.35	8.73	10.73	6.18
Return on Capital Employed (%)	14.01	12.81	10.94	14.54	9.24
Return on Assets (%)	8.44	8.71	7.11	8.55	4.83
Interest Coverage Ratio (x)	106.31	59.13	78.27	88.43	110.90
Asset Turnover Ratio (x)	0.52	0.59	0.54	0.71	64.93
Price to Earnings (x)	11.14	10.47	8.97	10.36	10.48
Price to Book (x)	1.21	1.08	0.78	1.11	0.65
EV/EBITDA (x)	7.68	7.80	6.12	6.98	5.43
EBITDA Margin (%)	25.35	21.16	18.80	19.13	12.42

Financial InsightsAlpa Labs

Income (P&L)
Cash Flow

- Quarterly Topline Performance
  Company witnessed QoQ revenue decline of 26.75%, which is lowest in the last 3 years. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 12.79% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
- Cash from Operations vs PAT
  Operating cash flow of Rs 7.06 cr is 0.36 times compared to the reported net profit of Rs 19.5 cr. (Source: Consolidated Financials)
- Decrease in Cash from Investing
  Company has used Rs 1.1 cr for investing activities which is an YoY decrease of 91.74%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Alpa Labs Technicals

Stock doesn't have any Buy/Sell Signals.
Price Analysis Data details are not available.
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR - - -

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	-	-	-

Alpa Labs Peer Comparison

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Alpa Labs Stock Performance	0.16	-1.18	-1.07	-3.86	-18.01	50.78	242.52
Medico Remedies Stock Performance	-0.61	-3.09	-0.13	-20.12	-14.48	90.90	0.00
Bafna Pharma Stock Performance	-1.67	-5.53	15.99	33.96	22.59	-9.96	0.00
Natural Capsule Stock Performance	-0.81	5.05	-2.47	-13.84	0.00	0.00	0.00
Aarey Drugs Stock Performance	2.75	12.75	6.54	29.03	0.74	73.89	0.00
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Alpa Labs	7.64	1.17	11.37	14.72	8.76	3.31	23.03	17.34	9.34	4.10	0.00	0.00
Medico Remedies	31.51	5.21	16.15	23.33	8.42	7.60	9.71	6.68	1.22	1.70	0.22	2.83
Bafna Pharma	28.35	4.58	0.00	-3.29	-34.67	19.21	-4.20	-57.54	-15.52	2.11	-0.71	-0.09
Natural Capsule	-38.35	0.83	0.26	2.85	0.14	7.60	5.38	0.36	0.23	1.30	0.45	3.88
Aarey Drugs	48.58	1.46	2.90	7.15	1.68	-0.78	2.13	0.84	1.84	2.20	0.25	3.61
Add More

Annual Ratios (%)

Choose from Peers

Krebs Biochem
Bal Pharma
Vaishali Pharma
Par Drugs & Chemical
Mangalam Drugs

Choose from Stocks

See All Parameters

Peers InsightsAlpa Labs

Do you find these insights useful?

hate it
meh
love it

Alpa Labs Shareholding Pattern

Loading...
Showing Alpa Labs Shareholding as on Jun 2025
Category Jun 2025 Mar 2025 Dec 2024 Sep 2024
Promoters 57.29 57.29 57.29 57.29
Pledge 0.00 0.00 0.00 0.00
FII 0.36 0.40 0.35 0.74
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 42.35 42.31 42.36 41.97
Showing Shareholding as on Jun 2025
Category No. of Shares Percentage % Change QoQ
Promoters 1,20,55,010 57.29 % 0.00
Pledge 0 0.00 % 0.00
FII 76,533 0.36 % -0.04
Others 89,09,057 42.35 % 0.03

Category	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Promoters	57.29	57.29	57.29	57.29
Pledge	0.00	0.00	0.00	0.00
FII	0.36	0.40	0.35	0.74
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	42.35	42.31	42.36	41.97

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,20,55,010	57.29 %	0.00
Pledge	0	0.00 %	0.00
FII	76,533	0.36 %	-0.04
Others	89,09,057	42.35 %	0.03

Alpa Labs MF Ownership

MF Ownership details are not available.

Alpa Labs Corporate Actions

Meeting Date	Announced on	Purpose	Details
Aug 13, 2025	Aug 01, 2025	Board Meeting	Quarterly Results & A.G.M.
May 28, 2025	May 19, 2025	Board Meeting	Audited Results
Feb 13, 2025	Feb 04, 2025	Board Meeting	Quarterly Results & Others
Nov 14, 2024	Nov 06, 2024	Board Meeting	Quarterly Results
Sep 28, 2024	Sep 18, 2024	AGM	A.G.M.

Dividend announcements are not available.
No other corporate actions details are available.

About Alpa Labs

Alpa Laboratories Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 200.03 Crore) operating in Pharmaceuticals sector. Alpa Laboratories Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Export Incentives, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023. Show More

Executives
Auditors

MS
Mahendra Singh Chawla
Chairman
PC
Paresh Chawla
Managing Director
JJ
Jyoti Jain
Independent Director
PL
Pratibha Lunawat
Independent Director
SB
Sanket Baheti
Independent Director
SK
Sunil Kumar Valecha
Independent Director
PS
Pravin Shah
Director
SS
Shitul Shah
Director
VK
Vitthal Kothana
Director
BS
Bakulesh Shah
Chief Financial Officer
SB
Swati Bagh
Co. Secretary & Compl. Officer
Show More
C H Padliya & Co.
Anuradha Ratnaparkhi & Associates

Industry

Pharma - Indian

Key Indices Listed on

Address

33/2, Pigdamber,A.B.Road, Rau,Indore, Madhya Pradesh - 453446

Contact

is@alpalabs.in

http://www.alpalabs.in

More Details

FAQs about Alpa Labs share

1. What's Alpa Labs share price today and what are Alpa Labs share returns ?
As on 08 Sep, 2025, 03:15 PM IST Alpa Labs share price is up by 0.04% basis the previous closing price of Rs 95.99. Alpa Labs share price is Rs 95.10. Return Performance of Alpa Labs Shares:
- 1 Week: Alpa Labs share price moved down by 1.31%
- 3 Month: Alpa Labs share price moved down by 3.98%
- 6 Month: Alpa Labs share price moved down by 12.58%
2. What are the returns for Alpa Labs share?
Return Performance of Alpa Labs Shares:
- 1 Week: Alpa Labs share price moved down by 1.31%
- 3 Month: Alpa Labs share price moved down by 3.98%
- 6 Month: Alpa Labs share price moved down by 12.58%
3. What's the market capitalization of Alpa Labs?
Within the Pharmaceuticals sector, Alpa Labs stock has a market cap rank of 96. Alpa Labs has a market cap of Rs 200.37 Cr.
4. What is the PE & PB ratio of Alpa Labs?
The PE ratio of Alpa Labs stands at 7.63, while the PB ratio is 1.17.
5. What has been highest price of Alpa Labs share in last 52 weeks?
In last 52 weeks Alpa Labs share had a high price of Rs 144.50 and low price of Rs 90.36

Trending in Markets

Top Gainers As on 03:59 PM | 08 Sep 2025

Suven Pharma 1,012.95

90.06 (9.76%)

Guj Mineral Dev.539.15

30.15 (5.93%)

Bharat Forge1,202.80

66.10 (5.82%)

Ashok Leyland137.29

6.52 (4.99%)

JP Power20.02

0.95 (4.99%)

Top Losers As on 03:57 PM | 08 Sep 2025

Amber Enterprises7,473.00

-320.50 (-4.12%)

EID Parry1,067.30

-45.50 (-4.09%)

Trent5,315.50

-213.00 (-3.86%)

Godfrey Philips10,657.00

-416.00 (-3.76%)

Coromandel Int.2,185.20

-72.71 (-3.22%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

ETPrime

Alpa Labs - Alpa Laboratories Share Price

Alpa Labs share price insights

InsightsAlpa Labs

Key Metrics

Key Metrics

Alpa Labs Share Price Returns

ET Stock ScreenersTop Score Companies

Alpa Labs News & Analysis

Alpa Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Alpa Labs Share Recommendations

Alpa Labs Financials

Insights

Insights

Financial InsightsAlpa Labs

Alpa Labs Technicals

Pivot Levels

Average True Range

Alpa Labs Peer Comparison

Ratio Performance

Peers InsightsAlpa Labs

Alpa Labs Shareholding Pattern

Alpa Labs MF Ownership

Alpa Labs Corporate Actions

About Alpa Labs

Executives

Auditors

More Details

FAQs about Alpa Labs share

Trending in Markets

Top Gainers As on 03:59 PM | 08 Sep 2025

Top Losers As on 03:57 PM | 08 Sep 2025

Alpa Labs Quick Links

Equity Quick Links

More from Markets

1 Day	-0.14%
1 Week	-1.09%
1 Month	-1.91%
3 Months	-4.25%
1 Year	-18.49%
3 Years	49.84%
5 Years	242.34%